Recommended

FDA tightens COVID vaccine use
Decentralised manufacturing consortium launched
Trial boost for myasthenia gravis drug
FDA starts publishing daily AE data
WEBINAR | The Future of Sterility Testing: One-Day Results with Advanced RT-rt PCR Technology | 5 NOV
WEBINAR | Mastering Impurity Profiling: USP’s Evolving Standards and Strategies | 15 OCT
Advertorial

Up to 10-fold increase in assay sensitivity – discover Morffi™ at MEDICA 2016

0
SHARES

Posted: 3 November 2016 | | No comments yet

BBI Solutions will be showcasing its Morffi™ signal enhancement technology on Stand F26 in Hall 1 at MEDICA 2016…

Up to 10-fold increase in assay sensitivity - discover Morffi™ at MEDICA 2016

BBI Solutions will be showcasing its Morffi™ signal enhancement technology on Stand F26 in Hall 1 at MEDICA 2016.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

Up to 10-fold increase in assay sensitivity - discover Morffi™ at MEDICA 2016

This year’s exhibition, which takes place in Dusseldorf from the 14th to the 17th of November, will give delegates a chance to explore this innovative technology and learn about the complete range of high quality raw materials and services the company offers to the IVD industry.

Morffi technology can improve performance for lateral flow immunoassays by increasing signal intensity and sensitivity up to 10-fold, as well as offering a faster time to result. Visitors to the stand will be able to discuss the potential of this novel conjugate blocking method, which is offered as part of BBI’s lateral flow development and OEM manufacturing services. The event will also be one of the first chances for customers to see the company’s recently extended portfolio, including a range of disease-specific antibodies and the new CellAdvance™ range of cell culture reagents. This expanded product offering represents an unparalleled source of high quality raw materials for the IVD market, backed by 30 years of BBI expertise in the lateral flow market. And if you still can’t find what you’re looking for, speak to the team about the company’s custom end-to-end assay development services, helping you to go from initial concept to final manufacture and beyond.

Join BBI Solutions on Stand F26 in Hall 1 at MEDICA 2016 to learn more about the future of lateral flow technology, or visit http://www.bbisolutions.com/events/medica-2016/ to pre-book an appointment with the team.

Share via
Share via